Journal of Dermatological Science
Volume 59, Issue 1 , Pages 31-39 , July 2010

Eugenol restricts DMBA croton oil induced skin carcinogenesis in mice: Downregulation of c-Myc and H-ras, and activation of p53 dependent apoptotic pathway

  • Debolina Pal

      Affiliations

    • Department of Oncogene Regulation, Chittaranjan National Cancer Institute, 37, S.P. Mukherjee Road, Kolkata 700026, India
    • ,
  • Sarmistha Banerjee

      Affiliations

    • Department of Oncogene Regulation, Chittaranjan National Cancer Institute, 37, S.P. Mukherjee Road, Kolkata 700026, India
    • ,
  • Sudeshna Mukherjee

      Affiliations

    • Department of Oncogene Regulation, Chittaranjan National Cancer Institute, 37, S.P. Mukherjee Road, Kolkata 700026, India
    • ,
  • Anup Roy

      Affiliations

    • Midnapur Medical College and Hospital, West Midnapur, West Bengal, India
    • ,
  • Chinmay K. Panda

      Affiliations

    • Department of Oncogene Regulation, Chittaranjan National Cancer Institute, 37, S.P. Mukherjee Road, Kolkata 700026, India
    • Corresponding Author InformationCorresponding author. Tel.: +91 33 2474 3922; fax: +91 33 2475 7606.
    • ,
  • Sukta Das

      Affiliations

    • Department of Oncogene Regulation, Chittaranjan National Cancer Institute, 37, S.P. Mukherjee Road, Kolkata 700026, India

Received 18 November 2009 ,Revised 19 April 2010 ,Accepted 26 April 2010.

References 

  1. Pisano M, Pagnan G, Loi M, et al. Antiproliferative and pro-apoptotic activity of eugenol-related biphenyls on malignant melanoma cells. Molecular Cancer. 2007;6:8–20
  2. Kim SS, Oh OJ, Min HY, et al. Eugenol suppresses cyclooxygenase-2 expression in lipopolysaccharide-stimulated mouse macrophage RAW264.7 cells. Life Sciences. 2003;73:337–348
  3. Ito M, Murakami K, Yoshino M. Antioxidant action of eugenol compounds: role of metal ion in the inhibition of lipid peroxidation. Food and Chemical Toxicology. 2005;43:461–466
  4. Miyazawa M, Hisama M. Suppression of chemical mutagen-induced SOS response by alkylphenols from clove (Syzygium aromaticum) in the Salmonella typhimurium TA1535/pSK1002 umu test. Journal of Agricultural and Food Chemistry. 2001;49:4019–4025
  5. Rompelberg CJ, Verhagen H, van Bladeren PJ. Effects of the naturally occurring alkenylbenzenes eugenol and trans-anethole on drug-metabolizing enzymes in the rat liver. Food and Chemical Toxicology. 1993;31:637–645
  6. Han EH, Hwang YP, Jeong TC, Lee SS, Shin JG, Jeong HG. Eugenol inhibit 7,12-dimethylbenz[a]anthracene-induced genotoxicity in MCF-7 cells: bifunctional effects on CYP1 and NAD(P)H:quinone oxidoreductase. FEBS Letters. 2007;581:749–756
  7. Abraham SK. Anti-genotoxicity of trans-anethole and eugenol in mice. Food and Chemical Toxicology. 2001;39:493–498
  8. Rompelberg CJ, Evertz SJ, Bruijntjes-Rozier GC, van den Heuvel PD, Verhagen H. Effect of eugenol on the genotoxicity of established mutagens in the liver. Food and Chemical Toxicology. 1996;34:33–42
  9. Yoo CB, Han KT, Cho KS, et al. Eugenol isolated from the essential oil of Eugenia caryophyllata induces a reactive oxygen species-mediated apoptosis in HL-60 human promyelocytic leukemia cells. Cancer Letters. 2005;225:41–52
  10. Gyoo-Cheon K, Don-Soo C, Jang-Seop L, et al. Caspases-dependent apoptosis in human melanoma cell by eugenol. The Korean Journal of Anatomy. 2006;39:245–253
  11. Shin SH, Park JH, Kim GC. The mechanism of apoptosis induced by eugenol in human osteosarcoma cells. Journal of Korean Oral Maxillofacial Surgery. 2007;33:20–27
  12. Sukumaran K, Unnikrishnan MC, Kuttan R. Inhibition of tumour promotion in mice by eugenol. Indian Journal of Physiology and Pharmacology. 1994;38:306–308
  13. Van Duuren BL, Goldschmidt BM. Cocarcinogenic and tumor-promoting agents in tobacco carcinogenesis. Journal of the National Cancer Institute. 1976;56:1237–1242
  14. Kaur G, Athar M, Alam MS. Eugenol precludes cutaneous chemical carcinogenesis in mouse by preventing oxidative stress and inflammation and by inducing apoptosis. Molecular Carcinogen. 2010;49:290–301
  15. Azuine MA, Amonkar AJ, Bhide SV. Chemopreventive efficacy of betel leaf extract and its constituents on 7,12-dimethylbenz(a)anthracene induced carcinogenesis and their effect on drug detoxification system in mouse skin. Indian Journal of Experimental Biology. 1991;29:346–351
  16. Waikel RL, Wang XJ, Roop DR. Targeted expression of c-Myc in the epidermis alters normal proliferation, differentiation and UV-B induced apoptosis. Oncogene. 1999;18:4870–4878
  17. Bianchi AB, Aldaz CM, Conti CJ. Nonrandom duplication of the chromosome bearing a mutated Ha-ras-1 allele in mouse skin tumors. Proceedings of the National Academy of Sciences of the United States of America. 1990;87:6902–6906
  18. Vaughan MB, Ramirez RD, Andrews CM, Wright WE, Shay JW. H-ras expression in immortalized keratinocytes produces an invasive epithelium in cultured skin equivalents. PLoS One. 2009;19:7908–7916
  19. Ise K, Nakamura K, Nakao K, et al. Targeted deletion of the H-ras gene decreases tumor formation in mouse skin carcinogenesis. Oncogene. 2000;19:2951–2956
  20. Oskarsson T, Essers MA, Dubois N, et al. Skin epidermis lacking the c-Myc gene is resistant to Ras-driven tumorigenesis but can reacquire sensitivity upon additional loss of the p21Cip1 gene. Genes & Development. 2006;20:2024–2029
  21. Ruggeri B, Caamano J, Goodrow T, DiRado M, Bianchi A, Trono D, et al. Alterations of the p53 tumor suppressor gene during mouse skin tumor progression. Cancer Research. 1991;51:6615–6621
  22. Kemp CJ, Donehower LA, Bradley A, Balmain A. Reduction of p53 dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell. 1993;74:813–822
  23. Saha P, Mandal S, Das A, Das S. Amarogentin can reduce hyperproliferation by downregulation of Cox-II and upregulation of apoptosis in mouse skin carcinogenesis model. Cancer Letters. 2006;244:252–259
  24. Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nature Reviews Cancer. 2003;3:768–780
  25. Ghosh R, Nadiminty N, Fitzpatrick JE, Alworth WL, Slaga TJ, Kumar AP. Eugenol causes melanoma growth suppression through inhibition of E2F1 transcriptional activity. The Journal of Biological Chemistry. 2005;280:5812–5819
  26. Banerjee S, Panda CK, Das S. Clove (Syzygium aromaticum L.), a potential chemopreventive agent for lung cancer. Carcinogenesis. 2006;27:1645–1654
  27. Manna S, Banerjee S, Mukherjee S, Das S, Panda CK. Epigallocatechin gallate induced apoptosis in Sarcoma180 cells in vivo: mediated by p53 pathway and inhibition in U1B, U4-U6 UsnRNAs expression. Apoptosis. 2006;11:2267–2276
  28. Ghosh A, Ghosh S, Maiti GP, et al. SH3GL2 and CDKN2A/2B loci are independently altered in early dysplastic lesions of head and neck: correlation with HPV infection and tobacco habit. The Journal of Pathology. 2009;217:408–419
  29. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. The Journal of Biological Chemistry. 1951;193:265–275
  30. Budiyanto A, Ahmed NU, Wu A, Bito T, Nikaido O, Osawa T, et al. Protective effect of topically applied olive oil against photocarcinogenesis following UVB exposure of mice. Carcinogenesis. 2000;21:2085–2090
  31. Kimura Y, Sumiyoshi M. Olive leaf extract and its main component oleuropein prevent chronic ultraviolet B radiation-induced skin damage and carcinogenesis in hairless mice. Journal of Nutrition. 2009;139:2079–2086
  32. Reichelt J, Furstenberger G, Magin TM. Loss of keratin 10 leads to mitogen-activated protein kinase (MAPK) activation, increased keratinocyte turnover, and decreased tumor formation in mice. The Journal of Investigative Dermatology. 2004;123:973–981
  33. Trumpp A. c-Myc and activated Ras during skin tumorigenesis: cooperation at the cancer stem cell level?. Ernst Schering Foundation Symposium Proceedings. 2006;13–26
  34. Henriksson M, Luscher B. Proteins of the Myc network: essential regulators of cell growth and differentiation. Advances in Cancer Research. 1996;68:109–182
  35. Jensen NA, Pedersen KM, Lihme F, et al. Astroglial c-Myc overexpression predisposes mice to primary malignant gliomas. The Journal of Biological Chemistry. 2003;278:8300–8308
  36. Hashimoto K, Nakagawa Y, Morikawa H, et al. Co-overexpression of DEAD box protein rck/p54 and c-myc protein in human colorectal adenomas and the relevance of their expression in cultured cell lines. Carcinogenesis. 2001;22:1965–1970
  37. Parikh C, Subrahmanyam R, Ren R. Oncogenic NRAS, KRAS, and HRAS exhibit different leukemogenic potentials in mice. Cancer Research. 2007;67:7139–7146
  38. Theodorescu D, Cornil I, Fernandez BJ, Kerbel RS. Overexpression of normal and mutated forms of HRAS induces orthotopic bladder invasion in a human transitional cell carcinoma. Proceedings of the National Academy of Sciences of the United States of America. 1990;87:9047–9051

PII: S0923-1811(10)00134-9

doi: 10.1016/j.jdermsci.2010.04.013

Journal of Dermatological Science
Volume 59, Issue 1 , Pages 31-39 , July 2010

Article Tools

* Image Usage & Resolution